Sorry but cant help lol. The company said they would be cash flow positive in around 2014 i believe, amongst other promises. You are entitled to your optimism though, i am naturally pessimistic and so far havent been dissapointed by pyc.
Hopefully you are right and we are all rewarded for keeping faith. As we all know the potential "appears to be there" but who knows what the reality is. If they can follow through with one or more myc inhibitors that they have commercial rights to and can show how they can be practically used within real cell cancer models then who knows. We just need to overcome the hurdle of no cpp currently being in commercial use then.
The response to those initial myc trials shows that regardless of the current commercial value though there is great interest in this technology and its development. Personally i think they have more potential than just the myc side of things. I was a little dissapointed when they seemed to narrow down to oncology after stating they wanted to "drug the undruggable". That is a huge field, and those impending trials by collaborators with cpp and drug payloads offer great short term potential.
Good luck to us all, were all on the same ship after all i guess
PYC Price at posting:
1.4¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)